Skip to main content
Log in

Subcutaneous estradiol pellets for endometrial preparation in donor oocyte recipients with a poor endometrial response

  • Clinical Assisted Reproduction
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Purpose: The purpose of this study was to evaluate the clinical effectiveness of subcutaneous estradiol pellets in donor oocyte recipients with an inadequate endometrial response.

Methods: The subjects were 13 women with ovarian failure and a maximal endometrial thickness <10 mm on standard estrogen regimens, as demonstrated during mock and/or prior oocyte donation cycles. They underwent pellet implantation (100–250 mg of estradiol) 6–13 weeks before oocyte donation.

Results: Maximal (mean ± SD) endometrial thickness was 8.7±1.5 mm on standard regimens, in contrast to 11.7± 1.8 mm on pellets, while estradiol levels were 674±844 and 815±706 pg/ml, respectively. The estradiol:estrone ratio on pellets was >1. There was 1 pregnancy with early loss during 10 cycles on other estrogen regimens and 12 pregnancies during 19 cycles on pellets. The pregnancy and implantation rates were, respectively, 63 and 27% on pellets and 41 and 14% on standard regimens in historical controls.

Conclusions: We conclude that estradiol pellets after a single administration provide constant estradiol levels extending into the first trimester of pregnancy, a physiologic estradiol:estrone ratio, and a better endometrial response than standard estrogen regimens. Implantation and pregnancy rates are higher. This approach may be especially suitable for recipients with a poor endometrial response.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Trounson A, Leeton JF, Besanko M, Wood C, Conti A: Pregnancy established in an infertile patient after transfer of a dontated embryo fertilized in vitro. Br Med J 1983;286:835–838

    Article  CAS  Google Scholar 

  2. Leeton J, Trounson A, Wood C: The use of donor eggs and embryos in the management of human infertility. Aust NZ J Obstet Gynaecol 1984;24:265–270

    CAS  Google Scholar 

  3. Rosenwaks Z: Donor eggs: Their application in modern reproductive technologies. Fertil Steril 1987;47:895–909

    PubMed  CAS  Google Scholar 

  4. Sauer MV, Paulson, RJ, Macaso TM, Francis-Hernandez M, Lobo RA: Establishment of a nonanonymous donor oocyte program: preliminary experience at the University of Southern California. Fertil Steril 1989;52:433–436

    PubMed  CAS  Google Scholar 

  5. Kennard EA, Collins RL, Blankstein J, Schover LR, Kanoti G, Reiss J, Quigley MM: A program for matched, anonymous oocyte donation. Fertil Steril 1989;51:655–660

    PubMed  CAS  Google Scholar 

  6. Navot D, Bergh PA, Williams M, Garrisi GJ, Guzman I, Sandler B, Fox J, Schreiner-Engel P, Hofmann GE, Grunfeld L: An insight into early reproductive processes through the in vivo model of ovum donation. J Clin Endocrinol Metab 1991;72:408–414

    Article  PubMed  CAS  Google Scholar 

  7. Flamigni C, Borini A, Violini F, Bianchi L, Serrao L: Oocyte donation: Comparison between recipients from different age groups. Hum Reprod 1993;8:2088–2092

    PubMed  CAS  Google Scholar 

  8. Edwards RG: Why are agonadol and post-amenorrhoeic women so fertile after oocyte donation? Hum Reprod 1992;7:733–734

    PubMed  CAS  Google Scholar 

  9. Asch RH: High pregnancy rates after oocyte and embryo donation. Hum Reprod 1992;7:734

    PubMed  CAS  Google Scholar 

  10. Abdalla HI, Brooks AA, Johnson MR, Kirkland A, Thomas A, Studd JWW: Endometrial thickness: A predictor of implantation in ovum recipients? Hum Reprod 1994;9:363–365

    PubMed  CAS  Google Scholar 

  11. Lutjen P, Trounson A, Leeton J, Findlay J, Wood C, Renou P: The establishment and maintenance of pregnancy using in vitro fertilization and embryo donation in a patient with primary ovarian failure. Nature 1984;307:174–175

    Article  PubMed  CAS  Google Scholar 

  12. Navot D, Laufer N, Kopolovic J, Rabinowitz R, Birkenfeld A, Lewin A, Granat M, Margalioth EJ, Schenker JG: Artificially induced endometrial cycles and establishment of pregnancies in the absence of ovaries. N Engl J Med 1986;314:806–811

    Article  PubMed  CAS  Google Scholar 

  13. Shushan A, Simon A, Reubinoff BE, Lewin A, Schenker JG, Laufer N: The use of vaginal tablets as a vehicle for steroid replacement in a donor oocyte program. Fertil Steril 1994;62:412–414

    PubMed  CAS  Google Scholar 

  14. Feinman M, Sher G, Massaranni G, Vaught L, Andreyko J, Salem R, Zouves C, Dodge S: High fecundity rates in donor oocyte recipients and in-vitro fertilization surrogates using parenteral oestradiol valerate. Hum Reprod 1993;8:1145–1147

    PubMed  CAS  Google Scholar 

  15. Kapetanakis E, Dmowski WP, Auletta F, Scommegna A: Endocrine and clinical effects of estradiol and testosterone pellets used in long-term replacement therapy. Int J Gynaecol Obstet 1982;20:387–399

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dmowski, W.P., Michalowska, J., Rana, N. et al. Subcutaneous estradiol pellets for endometrial preparation in donor oocyte recipients with a poor endometrial response. J Assist Reprod Genet 14, 139–144 (1997). https://doi.org/10.1007/BF02766129

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02766129

Key words

Navigation